News

›
24
Increase and Decrease in Nominal Share Value & Capital Return The company MEDICAL OF ATHENS E.A.E. informs the investing public that the Annual Ordinary General Meeting of Shareholders on Thursday, June 29, 2023, approved: a) the Increase in the company’s share capital by 2,602,079.40 euros with capitalization of part of the reserve from the account “Difference from the issuance of shares at par” and an increase in the nominal value of each share by the amount of 0.03 euros, i.e. from 0.31 euros to 0.34 euros and b) the equal simultaneous reduction in the company’s share capital...
20
Communication Iatriko Athens EAE announces that Mr. Anastasios Tagaris has left the Information Technology and New Technologies Department. The company thanks him for his contribution and cooperation and wishes him good success in his next professional steps.
13
ECONOMIC CALENDAR 2023 In the context of the Company’s obligations regarding the correct and timely information of the investing public, the company IATRIKO ATHENS E.A.E. announces the financial calendar for the year 2023: Announcement of Results for the Year 2022: Friday, April 28, 2023 Announcement to analysts: Tuesday, June 20, 2023 Announcement of Annual Ordinary General Meeting of Shareholders: Thursday, June 29, 2023 Announcement of Results for the First Half of 2023: Friday, September 29, 2023 The Company clarifies that the results will be announced o...
15
Fundamental Economic Figures for Q3 2022 IATRIKOU Athens Group, following the letter of the Capital Market Commission of 09/11/2022, which was communicated to all issuers with securities listed for trading on the regulated market of the Athens Stock Exchange, and with a view to valid and timely information of the investing public, in combination with the effects of the energy crisis, the military conflicts in Ukraine and the macroeconomic environment, we present to you a summary of the fundamental financial figures for the 9 months of 2022 as well as the 3rd quarter of fiscal year ...
30
Capital Market Commission – 3rd Quarter 2021 Athens Medical Group, following the letter of the Capital Market Commission of 09/11/2021, informs the investing public about the formation of fundamental financial figures and the developments of its activity for the 3rd quarter of 2021. Despite the continued spread of the Covid-19 pandemic, which has resulted in global uncertainty and the adoption of extraordinary restrictive measures, the Group’s financial results during the first nine months of 2021 were particularly positive, significantly increased compared to the first nine mont...
30
ATHENS MEDICAL CENTER UAE Athens Medical Center S.A.E., informs the investing public that on 24-09-2021 it signed the Common Bond Loan Issuance Program, based on the provisions of Codified Law 4548/2018 and Law 3156/2003, through a private placement with the banks NATIONAL BANK OF GREECE S.A., EFG EUROBANK ERGASIAS S.A. and ALPHA BANK S.A., with the latter as Administrator, for a total nominal value of €100,290,492, secured in rem, following the relevant decision of the Board of Directors dated 06-09-2021. The new Bond Loan provides for a repayment period until 2026 ...
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.